"The prevalence of TP53 mutation and primary resistance mechanisms in short-term responders to EGFR tyrosine kinase inhibitors in non-small cell lung cancer."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

e21237Background: Non-small cell lung cancer (NSCLC) with activating EGFR mutations in exon 19 or 21 usually responds to EGFR tyrosine kinase inhibitors (TKIs), but sometimes the responses can only... Click to show full abstract

Keywords: non small; cell lung; egfr tyrosine; lung cancer; small cell; tyrosine kinase

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended